CorMedix faces a sharp near-term revenue decline due to CMS reimbursement changes impacting DefenCath pricing starting in ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...